Citation Impact
Citing Papers
DiarrheagenicEscherichia coli
1998 Standout
Onchocerciasis: the clinical and epidemiological burden of skin disease in Africa
2002
Challenges in drug discovery for novel antifilarials
2007
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
2014 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
The transmission of onchocerciasis at a forest village in Sierra Leone. II. Man—fly contact, human activity and exposure to transmission
1990
L‐T3 preparation for whole‐body scintigraphy: a randomized‐controlled trial
2007
The life and times of ivermectin — a success story
2004 StandoutNobel
Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands
2000 Nature
Thyroid cancer
2016 Standout
Evaluation of the diethylcarbamazine patch to evaluate onchocerciasis endemicity in Central Africa
2006
Escherichia coli 0157:H7: Clinical, Diagnostic, and Epidemiological Aspects of Human Infection
1995
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Tetrahymenamicronuclear sequences that function as telomeres in yeast
1989 StandoutNobel
Nucleotide signalling during inflammation
2014 StandoutNature
Virulence factors and phenotypical traits of verotoxigenic strains of Escherichia coli isolated from human patients in Germany
1994
Risk of Hemolytic Uremic Syndrome After Antibiotic Treatment of Escherichia coli O157:H7 Enteritis
2002
Results of screening for verocytotoxin-producingEscherichia coli in faeces in Belgium
1990
Molecular cloning and nucleotide sequence of another variant of the Escherichia coli Shiga-like toxin II family
1990
Risk of hemolytic uremic syndrome after sporadic Escherichia coli O157:H7 infection: Results of a Canadian collaborative study
1998
Pelvic Radiation with Concurrent Chemotherapy Compared with Pelvic and Para-Aortic Radiation for High-Risk Cervical Cancer
1999 Standout
Lymphatic filariasis and onchocerciasis
2010 Standout
The role of antioxidant nutrients in preventing hyperbaric oxygen damage to the retina
1989 StandoutNobel
Generally Overlooked Fundamentals of Bacterial Genetics and Ecology
2002
Legumes and soybeans: overview of their nutritional profiles and health effects
1999 Standout
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
2005 Standout
First recognized community outbreak of haemorrhagic colitis due to verotoxin-producingEscherichia coliO 157.H7 in the UK
1988
Antibacterial resistance worldwide: causes, challenges and responses
2004 Standout
Hemolytic Uremic Syndrome and Diarrhea in Argentine Children: The Role of Shiga-like Toxins
1989
Escherichia coli cytotoxins and enterotoxins
1992
Effect of subinhibitory concentrations of antibiotics on extracellular shiga-like toxin I
1992
Adequate Thyroid-Stimulating Hormone Levels After Levothyroxine Discontinuation in the Follow-Up of Patients with Well-Differentiated Thyroid Carcinoma
2002
Strain-Specific Differences in the Amount of Shiga Toxin Released from Enterohemorrhagic Escherichia coli O157 following Exposure to Subinhibitory Concentrations of Antimicrobial Agents
1998
The Hemolytic Uremic Syndrome
1995
Pathogenic Escherichia coli
2004 Standout
Understanding the mechanisms and drivers of antimicrobial resistance
2015 Standout
Carcinoma of the urethra in women
1998
Rapid Diagnosis of EnterohemorrhagicEscherichia coliO157:H7 Directly from Fecal Specimens Using Immunofluorescence Stain
1994
Escherichia coli O157:H7
1998
Lessons learned in the management of hemolytic uremic syndrome in children
1995
Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology
2012 Standout
Escherichia coli O157:H7
2001
Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis
1992
Rapid Rise in Serum Thyrotropin Concentrations after Thyroidectomy or Withdrawal of Suppressive Thyroxine Therapy in Preparation for Radioactive Iodine Administration to Patients with Differentiated Thyroid Cancer
2004
Associations between filarial and gastrointestinal nematodes
2005
Escherichia coliO157:H7 and the Hemolytic–Uremic Syndrome
1995
The Central ScotlandEscherichia coliO157:H7 Outbreak: Risk Factors for the Hemolytic Uremic Syndrome and Death among Hospitalized Patients
2001
Childhood Vaccination
2016
Uncomplicated Urinary Tract Infection
2012 Standout
Reduction in incidence of optic nerve disease with annual ivermectin to control onchocerciasis
1993
Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection
1997 Standout
Synthesis and Microcontact Printing of Dual End‐Functionalized Mucin‐like Glycopolymers for Microarray Applications
2009 StandoutNobel
Combinations of Rifampin or Rifabutine plus Ethambutol against Mycobacterium avium Complex: Bactericidal Synergistic, and Bacteriostatic Additive or Synergistic Effects
1988
Incomplete hemolytic-uremic syndrome in Argentinean children with bloody diarrhea
1995
Shiga-like toxin-producing Escherichia coli in Seattle children: A prospective study
1993
Microfluidic diagnostic technologies for global public health
2006 StandoutNature
Helminth infections: the great neglected tropical diseases
2008 Standout
Bifidobacteria can protect from enteropathogenic infection through production of acetate
2011 StandoutNature
Control of Neglected Tropical Diseases
2007 Standout
Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens
2008 Standout
Daily bowel movements and Escherichia coli O157 infection
2002
The Exclusivity of Multivalency in Dynamic Covalent Processes
2004 StandoutNobel
Antibiotic-Associated Diarrhea
2002 Standout
Cardiovascular and renal benefits of dry bean and soybean intake
1999
Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: Clinical and epidemiologic observations
1990
Genetic Evidence of Clonal Descent of Escherichia coli O157:H7 Associated with Hemorrhagic Colitis and Hemolytic Uremic Syndrome
1988
Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce
2006 Standout
Control of Onchocerciasis
2006
Transfer of multiple drug resistance plasmids between bacteria of diverse origins in natural microenvironments
1994
Effect of single-dose ivermectin therapy on human Onchocerca volvulus infection with onchocercal ocular involvement.
1988
Treatment of Onchocerciasis
1986
Pharmaceuticals, Hormones, and Other Organic Wastewater Contaminants in U.S. Streams, 1999−2000: A National Reconnaissance
2002 Standout
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013
2017 Standout
Density Variant Glycan Microarray for Evaluating Cross-Linking of Mucin-like Glycoconjugates by Lectins
2012 StandoutNobel
The Nonimpact of Thyroid Stunning: Remnant Ablation Rates in 131I-Scanned and Nonscanned Individuals
2001
Roles of the 2 microns gene products in stable maintenance of the 2 microns plasmid of Saccharomyces cerevisiae.
1987 StandoutNobel
Use of Antimicrobial Agents in Animal Feeds: Implications for Human Health
1987
Infection by verocytotoxin-producing Escherichia coli
1989
Temperature range for growth of Escherichia coli serotype O157:H7 and selected coliforms in E. coli medium
1990
Practice Guidelines for the Management of Infectious Diarrhea
2001
Effects of High Oxygen Pressures on the Eye
1969
Chemical Glycobiology
2001 StandoutScienceNobel
Pedigree analysis of plasmid segregation in yeast
1983 StandoutNobel
A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens.
1995 Standout
Changes of free calcium levels with stages of the cell division cycle
1985 StandoutNatureNobel
Examination of diarrheagenicity of cytolethal distending toxin: suckling mouse response to the products of the cdtABC genes of Shigella dysenteriae
1997
The Global Enteric Multicenter Study (GEMS): Impetus, Rationale, and Genesis
2012
Maintenance of the 2 microns circle plasmid in populations of Saccharomyces cerevisiae
1983
The Risk of the Hemolytic–Uremic Syndrome after Antibiotic Treatment ofEscherichia coliO157:H7 Infections
2000
Changing Patterns of Plasmid-Mediated Drug Resistance During Tetracycline Therapy
1977
DNA probes for Shiga-like toxins I and II and for toxin-converting bacteriophages
1988
Suramin: With Special Reference to Onchocerciasis
1978
Occurrence of Shiga-like toxin-producing Escherichia coli in retail fresh seafood, beef, lamb, pork, and poultry from grocery stores in Seattle, Washington
1994
Escherichia coli O157:H7-associated colitis. A clinical and histological study of 11 cases.
1990
Improvement in severe onchocercal skin disease after a single dose of ivermectin
1991
Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: The LUTIW project
2007
Structure of the Shiga-like Toxin I B-Pentamer Complexed with an Analogue of Its Receptor Gb3,
1998
Cloning and sequencing of the genes encoding Escherichia coli cytolethal distending toxin
1994
Controlled Trial and Dose-Finding Study of Ivermectin for Treatment of Onchocerciasis
1987
Human infection patterns and heterogeneous exposure in river blindness
2005
A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells.
1990 Standout
Persistence of Transferable Extended-Spectrum-β-Lactamase Resistance in the Absence of Antibiotic Pressure
2012
Detection of Shiga toxin-producing Shigella dysenteriae type 1 and Escherichia coli by using polymerase chain reaction with incorporation of digoxigenin-11-dUTP
1991
Genetic relationships among pathogenic Escherichia coli of serogroup O157
1988
Experimental infection of calves and adult cattle with Escherichia coli O157:H7
1995
Inter- and intraspecies spread of Escherichia coli in a farm environment in the absence of antibiotic usage.
1990
Molecular detection of sorbitol-fermenting Escherichia coli O157 in patients with hemolytic-uremic syndrome
1992
The Nonimpact of Thyroid Stunning: Remnant Ablation Rates in 131I-Scanned and Nonscanned Individuals
2001
Changes in intracellular pH of plasmodium during the cell cycle and in response to starvation
1982
HLA-D alleles associated with generalized disease, localized disease, and putative immunity in Onchocerca volvulus infection.
1994
Preparation of patients with thyroid cancer for 131I scintigraphy or therapy by 1-3 weeks of thyroxine discontinuation.
2004
Can Multivalency Be Expressed Kinetically? The Answer Is Yes
2004 StandoutNobel
The Escherichia coli K-12 gntP gene allows E. coli F-18 to occupy a distinct nutritional niche in the streptomycin-treated mouse large intestine
1996
Enterohemorrhagic Escherichia coli associated with hemolytic-uremic syndrome in Chilean children
1992
A DNA Probe to Identify Enterohemorrhagic Escherichia coli of 0157:H7 and Other Serotypes That Cause Hemorrhagic Colitis and Hemolytic Uremic Syndrome
1987
Canarypox Virus-Induced Maturation of Dendritic Cells Is Mediated by Apoptotic Cell Death and Tumor Necrosis Factor Alpha Secretion
2000 StandoutNobel
A reporter transgene indicates renal-specific induction of tumor necrosis factor (TNF) by shiga-like toxin. Possible involvement of TNF in hemolytic uremic syndrome.
1993 StandoutNobel
Roles of the 2μm Gene Products in Stable Maintenance of the 2μm Plasmid of Saccharomyces cerevisiae
1987 StandoutNobel
Attaching and effacing adherence of Vero cytotoxin-producing Escherichia coli to rabbit intestinal epithelium in vivo
1988
Some structures and processes of human epithelial cells involved in uptake of enterohemorrhagic Escherichia coli O157:H7 strains
1994
Radioiodsne-131 In the Diagnosis and Treatment of Metastatic Weil Differentiated Thyroid Cancer
1990
Close association of verotoxin (Shiga-like toxin) production with enterohemolysin production in strains of Escherichia coli
1989
Surface properties of the Vero cytotoxin-producing Escherichia coli O157:H7
1987
Improvement in severe onchocercal skin disease after a single dose of ivermectin
1991
Identifying sub-optimal responses to ivermectin in the treatment of River Blindness
2009
Pathogenesis and Diagnosis of Shiga Toxin-Producing Escherichia coli Infections
1998 Standout
Development and evaluation of enzyme-linked immunosorbent assays for detection of shiga-like toxin I and shiga-like toxin II
1989
Screening for Escherichia coli O157:H7--a nationwide survey of clinical laboratories
1995
Mechanisms of Endocytosis
2009 Standout
Predictors of Hemolytic Uremic Syndrome in Children During a Large Outbreak ofEscherichia coliO157:H7 Infections
1997
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
Evaluation of oligonucleotide probes for identification of shiga-like-toxin-producing Escherichia coli
1989
Mycobacterium aviumComplex Infection in the Acquired Immunodeficiency Syndrome
1991 Standout
Thyroid carcinoma
2003 Standout
Characterization of Escherichia coli serotype O157:H7
1988
Escherichia coli that Cause Diarrhea: Enterotoxigenic, Enteropathogenic, Enteroinvasive, Enterohemorrhagic, and Enteroadherent
1987
Works of John Anderson being referenced
Some aspects of onchocerciasis in Sudan savanna and rain-forest.
1977
The clinicopathological picture of onchocerciasis in Ethiopia.
1977
Distributional impact of rotavirus vaccination in 25 GAVI countries: Estimating disparities in benefits and cost-effectiveness
2012
Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolytic-uremic syndrome
1990
Antibiotics for Escherickia coli 0157: H7 enteritis?
1989
Studies on the dynamics of transmission of onchocerciasis in a Sudan-savanna area of North Cameroon IV
1987
Improved biochemical screening procedure for small clinical laboratories for vero (Shiga-like)-toxin-producing strains of Escherichia coli O157:H7
1986
Low Dose Combined Chemotherapy/Radiotherapy in the Management of Locally Advanced Urethral Squamous Cell Carcinoma
1989
Effects of various concentrations of diethylcarbamazine citrate applied as eye drops in ocular onchocerciasis, and the possibilities of improved therapy from continuous non-pulsed delivery.
1978
Studies on onchocerciasis in the United Cameroon Republic. V. A four year follow-up of 6 rain-forest and 6 Sudan-savanna villages. Some changes in skin and lymph nodes
1979
Effects of diethylcarbamazine on ocular onchocerciasis.
1976
Studies on onchocerciasis in the United Cameroon Republic II. Comparison of onchocerciasis in rain-forest and Sudan-savanna
1974
SOYBEAN FACTORS RELATING TO GAS PRODUCTION BY INTESTINAL BACTERIA
1970
Evaluation of microfilaricidal effects in the cornea from topically applied drugs in ocular onchocerciasis: Trials with levamisole and mebendazole.
1978
Serial TSH determination after T3 withdrawal or thyroidectomy in the therapy of thyroid carcinoma.
1979
Changes in visual function and in the posterior segment of the eye during treatment of onchocerciasis with diethylcarbamazine citrate.
1980
Collapse during treatment of onchocerciasis with diethylcarbamazine
1974
CHEMOTHERAPY AND ANTIBIOTIC-RESISTANCE TRANSFER BETWEEN ENTEROBACTERIA IN THE HUMAN GASTRO-INTESTINAL TRACT
1973
Further Evidence Associating Hemolytic Uremic Syndrome with Infection by Verotoxin-Producing Escherichia coli O157:H7
1986
Further studies on the treatment of ocular onchocerciasis with diethylcarbamazine and suramin.
1978
Studies on onchocerciasis in the United Cameroon Republic
1976
Potentials and ionic exchange in slime mold plasmodia
1968
Morphology of posterior segment lesions of the eye in patients with onchocerciasis.
1976
FACTORS THAT MAY PREVENT TRANSFER OF ANTIBIOTIC RESISTANCE BETWEEN GRAM-NEGATIVE BACTERIA IN THE GUT
1975
Comparative activity of mecillinam and ampicillin singly and in combination in the urinary bladder model and experimental mouse model
1981
Gastroenteritis and encephalopathy associated with a strain of Escherichia coli 055:K59:H4 that produced a cytolethal distending toxin.
1987
Effects of suramin on ocular onchocerciasis.
1976
The cause of blindness in dogs given hydroxypyridinethione
1962
The Effect of R-Factor Carriage on the Survival of Escherichia Coli In The Human Intestine
1974
Variation in delayed hypersensitivity in onchocerciasis
1978
Studies on onchocerciasis in the United Cameroon Republic I. Comparison of populations with and without Onchocerca volvulus
1974
Onchocerciasis in Yemen with special reference to sowda
1973
STUDIES ON THE NATURE OF PLASMIDS ARISING FROM CONJUGATION IN THE HUMAN GASTRO-INTESTINAL TRACT
1973
Onchocerciasis and Its Treatment
1972
Escherichia coli 0157: H7 infections associated with perforated appendicitis and chronic diarrhoea
1990
Onchocerciasis in Guatemala
1981
Onchocercal Dermatitis: Ultrastructural Studies of Microfilariae and Host Tissues, before and after Treatment with Diethylcarbamazine (Hetrazan®)
1976
Urinary Excretion of Mecillinam by Volunteers Receiving Film-Coated Tablets of Pivmecillinam Hydrochloride
1979